Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.

Suzuki S, Yamane T, Mohri M, Kaneko A.

Ophthalmology. 2011 Oct;118(10):2081-7. doi: 10.1016/j.ophtha.2011.03.013. Epub 2011 Jun 29.

PMID:
21715012
2.

Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.

Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY.

Jpn J Ophthalmol. 2015 Mar;59(2):109-17. doi: 10.1007/s10384-014-0356-y. Epub 2014 Dec 3.

PMID:
25465196
3.

Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.

Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S.

Retina. 2011 Mar;31(3):566-73. doi: 10.1097/IAE.0b013e318203c101.

PMID:
21273941
4.

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.

Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.

PMID:
18342944
5.

Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.

Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.

Ophthalmology. 2012 Mar;119(3):611-6. doi: 10.1016/j.ophtha.2011.08.045. Epub 2011 Dec 22.

PMID:
22197434
6.

Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).

Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.

Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.

PMID:
20381868
7.

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.

Yamane T, Kaneko A, Mohri M.

Int J Clin Oncol. 2004 Apr;9(2):69-73.

PMID:
15108036
8.

Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.

Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.

Ophthalmology. 2012 Jan;119(1):188-92. doi: 10.1016/j.ophtha.2011.06.036. Epub 2011 Oct 5.

PMID:
21975042
9.

Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.

Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH.

Doc Ophthalmol. 2009 Aug;119(1):13-22. doi: 10.1007/s10633-008-9164-3. Epub 2009 Jan 25.

PMID:
19169884
10.

Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.

Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.

Pediatr Blood Cancer. 2013 May;60(5):766-70. doi: 10.1002/pbc.24356. Epub 2012 Sep 28.

PMID:
23024125
11.

Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.

Venturi C, Bracco S, Cerase A, Cioni S, Galluzzi P, Gennari P, Vallone IM, Tinturini R, Vittori C, De Francesco S, Caini M, D'Ambrosio A, Toti P, Renieri A, Hadjistilianou T.

Acta Ophthalmol. 2013 Jun;91(4):335-42. doi: 10.1111/j.1755-3768.2011.02296.x. Epub 2012 Jan 23.

12.

Ophthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.

Abramson DH, Marr BP, Brodie SE, Dunkel I, Palioura S, Gobin YP.

PLoS One. 2012;7(4):e34120. doi: 10.1371/journal.pone.0034120. Epub 2012 Apr 24.

13.

Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma.

Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, Roebuck D, Hungerford JL, Herod J.

Paediatr Anaesth. 2013 Oct;23(10):940-5. doi: 10.1111/pan.12162. Epub 2013 May 13.

PMID:
23668238
14.

Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.

Tsimpida M, Thompson DA, Liasis A, Smith V, Kingston JE, Sagoo MS, Reddy MA.

Br J Ophthalmol. 2013 Nov;97(11):1464-70. doi: 10.1136/bjophthalmol-2013-303694. Epub 2013 Sep 13.

PMID:
24037611
15.

Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.

Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.

Ophthalmology. 2014 Jul;121(7):1453-60. doi: 10.1016/j.ophtha.2014.01.026. Epub 2014 Mar 21.

PMID:
24656794
16.

Intravitreal injection of melphalan for intraocular retinoblastoma.

Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A.

Jpn J Ophthalmol. 2015 May;59(3):164-72. doi: 10.1007/s10384-015-0378-0. Epub 2015 Mar 26.

PMID:
25808017
17.

Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.

Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.

Arch Ophthalmol. 2011 Nov;129(11):1399-406. doi: 10.1001/archophthalmol.2011.150. Epub 2011 Jun 13.

PMID:
21670328
18.

Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.

Akyüz C, Kıratlı H, Şen H, Aydın B, Tarlan B, Varan A.

Ophthalmologica. 2015;234(4):227-32. doi: 10.1159/000439357. Epub 2015 Sep 15.

PMID:
26368674
19.

Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.

Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.

J Neurosurg. 2011 Jun;114(6):1603-8. doi: 10.3171/2011.1.JNS10466. Epub 2011 Feb 4.

PMID:
21294621
20.

Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.

Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA.

Ophthalmology. 2012 Apr;119(4):843-9. doi: 10.1016/j.ophtha.2011.09.040. Epub 2011 Dec 2.

PMID:
22137042
Items per page

Supplemental Content

Write to the Help Desk